Singapore markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.1900+0.1000 (+4.78%)
At close: 04:00PM EDT
2.1801 -0.01 (-0.45%)
After hours: 06:58PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.0900
Open2.1300
Bid2.1800 x 2800
Ask2.2100 x 1000
Day's range2.0700 - 2.2150
52-week range0.7000 - 3.4000
Volume9,420,462
Avg. volume6,957,908
Market cap414.788M
Beta (5Y monthly)0.82
PE ratio (TTM)N/A
EPS (TTM)-2.0300
Earnings date30 Jul 2024 - 05 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est7.41
  • GlobeNewswire

    Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    ANN ARBOR, Mich., May 10, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on May 8, 2024, the Company granted 16 new employees 62,300 restricted stock units (RSUs) under Esperion’s 2017 Inducement Equity Incentive Plan. The 2017 Inducement Equity Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Esperion (or following a bona fide period of non-employment), as an inducement materia

  • Zacks

    Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues

    Esperion's (ESPR) first-quarter earnings and sales beat estimates on the back of better-than-expected collaboration revenues.

  • Insider Monkey

    Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2024 Earnings Call Transcript

    Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2024 Earnings Call Transcript May 7, 2024 Esperion Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.00032, expectations were $-0.17. ESPR isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for […]